Evidence Review
World J Diabetes
13(6):422-433.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.422
Abstract (764)
|
Core Tip (771)
|
Full Article (HTML) (3924)
|
Tables (1-4) (780)
|
Full Article (PDF)-727K (384)
|
Audio-1990K (4)
|
Peer-Review Report-250K (119)
|
Answering Reviewers-101K (111)
|
Received: 12/20/2021
|
Revised: 05/01/2022
|
Accepted: 05/23/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (9622)
|
Similar Articles (251)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (4)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Diabetes
13(6):434-441.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.434
Abstract (632)
|
Core Tip (686)
|
Article Highlights (780)
|
Full Article (HTML) (2381)
|
Figures (1-3) (459)
|
Full Article (PDF)-850K (277)
|
Audio-285K (4)
|
Peer-Review Report-401K (126)
|
Answering Reviewers-153K (127)
|
Received: 01/27/2022
|
Revised: 04/24/2022
|
Accepted: 05/28/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8512)
|
Similar Articles (4)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Diabetes
13(6):442-453.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.442
Abstract (697)
|
Core Tip (735)
|
Article Highlights (763)
|
Full Article (HTML) (3171)
|
Figures (1-8) (456)
|
Full Article (PDF)-5732K (282)
|
Audio-276K (8)
|
Peer-Review Report-533K (115)
|
Answering Reviewers-58K (124)
|
Received: 03/01/2022
|
Revised: 04/25/2022
|
Accepted: 05/23/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (9495)
|
Similar Articles (21)
|
Timeline of Article Publication (3)
|
Authors Evaluation (1)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective study
![](https://www.f6publishing.com/contents/images/coretip.png)
World J Diabetes
13(6):454-465.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.454
Abstract (594)
|
Core Tip (775)
|
Article Highlights (824)
|
Full Article (HTML) (2084)
|
Figures (1-3) (440)
|
Tables (1-3) (440)
|
Full Article (PDF)-1761K (280)
|
Audio-343K (8)
|
Peer-Review Report-225K (110)
|
Answering Reviewers-124K (104)
|
Received: 01/14/2022
|
Revised: 04/18/2022
|
Accepted: 05/28/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (9162)
|
Similar Articles (144)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (3)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
World J Diabetes
13(6):466-470.
Published online Jun 15, 2022.
doi: 10.4239/wjd.v13.i6.466
Abstract (661)
|
Core Tip (702)
|
Full Article (HTML) (2569)
|
Tables (1-1) (404)
|
Full Article (PDF)-641K (357)
|
Audio-743K (4)
|
Peer-Review Report-179K (102)
|
Answering Reviewers-121K (89)
|
Received: 03/07/2022
|
Revised: 04/19/2022
|
Accepted: 05/23/2022
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (7334)
|
Similar Articles (1)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (4)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open